Dedicated to women's health and well-being

News

FDA Seeks Feedback on Lasik Surgery

FDA Seeks Feedback on Lasik Surgery

October 16, 2009 - 11:53am 161 reads 0 comments

FRIDAY, Oct. 16 (HealthDay News) -- The percentage of patients who experience serious quality-of-life problems after Lasik eye surgery is being studied by the U.S. Food and Drug Administration, which has also issued warning letters to a number of Lasik facilities that weren't properly reporting problems with the procedure.

The FDA study, which will also identify factors that predict quality-of-life problems in Lasik patients, has three phases. Phase 1, launched in July 2009, involves the design and launch of a Web-based questionnaire to assess patient-reported outcomes and evaluate quality-of-life issues after the laser-assisted eye surgery.

Phase 2 will examine quality of life and satisfaction among patients treated at the Navy Refractive Surgery Center, and phase 3 will be a national, multi-center clinical trial to study quality of life after Lasik among the general population.

Click here to comment on this article.

"This study will enhance our understanding of the risks of Lasik and could lead to a reduction in patients who experience adverse effects from the procedure," Dr. Jeffrey Shuren, acting director of the FDA's Center for Devices and Radiological Health, said in an agency news release.

If the study identifies any problems with the safety or effectiveness of the lasers used in Lasik surgery, the agency will evaluate whether any action is necessary.

In related news, the FDA also noted in the release that it issued warning letters to 17 Lasik ambulatory surgical centers after inspections revealed that the centers had inadequate systems for reporting problems suffered by patients. The types of problems were specified.

"Many people in the U.S. undergo Lasik procedures. Ambulatory surgical centers that perform Lasik must maintain a robust reporting system as required by law," Shuren said in the news release. "Reporting adverse events to the FDA is critical to better understand the safety and effectiveness of ophthalmic lasers used in Lasik procedures and to enable the FDA to take appropriate actions where the lasers do not meet safety and effectiveness requirements."

Add A New Comment

Start Asking & Sharing



Add A New CommentComments

There are no comments yet. Be the first to get the conversation started.

Log in

Are you a member? Log in first to track your posts

Not a member? Join us. Membership is not required to post.

More information about formatting options

We never share email addresses with third parties. Your email address will be used to notify you of activity on your post and send you our newsletter if you choose to sign up for it.
Verify that you are a human (not a computer):
This is necessary to prevent computer programs from automatically posting spam or other irrelevant content on EmpowHER.com. Enter the characters in the box to the left (case sensitive). Do not enter spaces between the characters.
Image CAPTCHA

What Do YOU Think? We want to know so we can help!

Poll
Do you have sleep apnea?:
View Results

Free Weekly Newsletter

Sign up for EmpowHER's weekly newsletter